Fulgar and the Rhodia-Solvay Group collaborates for AMNI® VIRUS-BAC OFF technology

Amid the lingering threat posed by Covid, the return to offices and schools has created an exponentially risisng demand for garments given anti-bacterial and antiviral protection treatments. This demand among consumers and workers has led many manufacturing companies in Italy and the rest of Europe to prioritise such products.

This is the background to the arrival in Europe of the new Rhodia-Solvay yarn. The Brazilian group has chosen the know-how and expertise provided by Fulgar, a centre of Made in Italy excellence in the development and manufacture of innovative man-made yarn, for the production and European distribution of AMNI® VIRUS-BAC OFF technology, the new antiviral and anti-microbial polyamide yarn introduced in Europe by Fulgar under the name of Q-SKIN® powered by AMNI® VIRUS-BAC OFF.

These properties are the result of antiviral and anti-bacterial agent permanently incorporated into the polymer matrix. Developed in record time by the Rhodia-Solvay research laboratories in Paulínia and Santo André, Brazil, this extraordinary polyamide yarn acts against bacterial growth and virus transmission.

Electrical affinity with the proteins present in the external structure of the virus enables this agent to prevent the fabric from becoming a host surface enabling the spread of the harmful viruses and bacteria and reducing the risk and speed of contamination.